Physician profile
Phillip E Dowd
NPI 1053394627
$4,360.07
in general payments reported to CMS, 2019-2025
37 companies · $637 in 2025
The $637 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $330 · 2021: $543 · 2022: $683 · 2023: $921 · 2024: $555 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,113.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $826.17 | 2019-2024 | Myrbetriq |
| Janssen Biotech, INC. | $570.58 | 2019-2024 | Erleada |
| Boston Scientific Corporation | $504.53 | 2019-2025 | Moses 550 D\F\L, Lithovue, Greenlight Xps |
| Procept Biorobotics Corporation | $255.95 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Convatec INC. | $223.14 | 2022-2024 | |
| Abbvie INC. | $193.47 | 2019-2022 | |
| Urogen Pharma, INC. | $135.79 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $128.78 | 2020-2025 | Adstiladrin |
| Coloplast Corp | $126.80 | 2020-2025 | Saffron, Titan |
| Myovant Sciences INC. | $110.57 | 2021 | |
| Sumitomo Pharma America, INC. | $100.04 | 2025 | Gemtesa |
| Teleflex LLC | $97.17 | 2021-2025 | Barrigel, Urolift |
| Avation Medical, INC. | $86.76 | 2025 | Vivally System |
| Neotract INC. | $85.80 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $82.61 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $78.01 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ambu INC. | $62.25 | 2020-2022 | |
| Innovation Technologies INC | $56.83 | 2023-2024 | Irrisept |
| Cook Medical LLC | $53.86 | 2020-2024 | Resonance |
| Merck Sharp & Dohme LLC | $50.44 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Dendreon Pharmaceuticals LLC | $47.51 | 2020-2024 | Provenge |
| Progenics Pharmaceuticals, INC. | $44.80 | 2025 | |
| Medtronic, INC. | $44.60 | 2022-2025 | Signia |
| 180 Medical, INC. | $43.79 | 2023-2024 | Gentlecath |
| Pfizer INC. | $42.03 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $40.81 | 2023 | |
| Baxter Healthcare | $34.74 | 2025 | Floseal |
| Genzyme Corporation | $34.51 | 2019 | |
| Axonics, INC. | $30.37 | 2022-2024 | Axonics, Bulkamid |
| Photocure INC | $25.97 | 2019 | |
| Endo USA, INC. | $23.91 | 2025 | Aveed, Xiaflex |
| Civco Medical Instruments | $23.71 | 2024 | |
| Isoray, INC | $22.28 | 2020 | |
| Valencia Technologies Corporation | $19.31 | 2025 | Ecoin Device Kit |
| Olympus America INC. | $18.47 | 2023 | Olympus |
| Tolmar, INC. | $17.66 | 2024 | |
| Endo Pharmaceuticals INC. | $16.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Dowd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.